# Bioequivalence Study of Levetiracetam 1500 mg Coated Granules in Healthy, Male Subjects

> **NCT07393022** · PHASE1 · COMPLETED · sponsor: **Desitin Arzneimittel GmbH** · enrollment: 20 (actual)

## Conditions studied

- Pharmacokinetic Analysis
- Bioequivalence
- Health Adult Subjects

## Interventions

- **DRUG:** Levetiracetam 1500 mg
- **DRUG:** Keppra® 750 mg

## Key facts

- **NCT ID:** NCT07393022
- **Lead sponsor:** Desitin Arzneimittel GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-12-17
- **Primary completion:** 2026-01-05
- **Final completion:** 2026-01-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07393022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07393022, "Bioequivalence Study of Levetiracetam 1500 mg Coated Granules in Healthy, Male Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07393022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*